About: Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID‐19 patient with ST‐elevation myocardial infarction

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID‐19 patient with ST‐elevation myocardial infarction Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID‐19 patient with ST‐elevation myocardial infarction
Creator	Kumar, Abhishek Macdonald, John Ayuna, Ahmed Seif, Sherif
Source	Medline; PMC
abstract	COVID‐19 is a new viral infection that has a significant impact on global health and economy. Because of its rapid spread worldwide, it may influence the prognosis of other medical conditions, such as ST‐segment elevation myocardial infarction (STEMI). We report a case of a 58‐year female patient admitted with an infero‐posterior STEMI on the background of recently positive COVID‐19 swab. Reperfusion was attempted through primary PCI but unfortunately failed to restore coronary blood flow due to massive thrombotic burden despite several attempts of balloon dilatation and aspiration thrombectomy. She sadly died later on because of hemodynamic deterioration. This scenario raises concerns about Neutrophil Extracellular Traps (NETS) which might potentially have propagated inflammation and thrombosis via platelets' aggregation leading to enhanced coagulopathy and massive coronary thrombosis. Therefore, we suggest primary PCI as the first‐choice of revascularization in patients with combined COVID‐19 and STEMI. Additionally, we emphasize on the importance of using the potent new generation P2Y12 inhibitors along with GPIIb/IIIa inhibitors in every STEMI patient with COVID‐19 to achieve favorable conditions for primary PCI as well as favorable outcomes after stent implantation.
has issue date	2020-05-30(xsd:dateTime)
bibo:doi	10.1002/ccd.29050
bibo:pmid	32473051
has license	no-cc
sha1sum (hex)	96325c138fa9aaf1d0e950e51d1174615ee64747
schema:url	https://doi.org/10.1002/ccd.29050
resource representing a document's title	Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID‐19 patient with ST‐elevation myocardial infarction
has PubMed Central identifier	PMC7300872
has PubMed identifier	32473051
schema:publication	Catheter Cardiovasc Interv
resource representing a document's body	covid:96325c138fa9aaf1d0e950e51d1174615ee64747#body_text
is schema:about of	named entity 'COVID-19' named entity 'background' named entity 'medical conditions' named entity 'coronary thrombosis' named entity 'COVID-19' named entity 'BALLOON DILATATION' named entity 'SWAB' named entity 'YEAR' named entity 'global health' named entity 'positive' named entity 'patient' named entity 'COVID-19' named entity 'thrombotic' named entity 'Reperfusion' named entity 'prognosis' named entity 'direct action' named entity 'STEMI' named entity 'coronary artery' named entity 'acute kidney injury' named entity 'leucocytosis' named entity 'thrombotic' named entity 'prognosis' named entity 'infusion' named entity 'catheter' named entity 'coagulopathy' named entity 'thrombotic' named entity 'Coronary angiography' named entity 'acute inflammatory response' named entity 'catheterization' named entity 'cardiology' named entity 'eGFR' named entity 'aspirin' named entity 'COVID-19' named entity 'loading dose' named entity 'ticagrelor' named entity 'April 30' named entity 'creatinine' named entity 'catheter' named entity 'thrombus' named entity 'SARS-CoV-2' named entity 'thrombotic' named entity 'acute myocardial infarction' named entity 'fondaparinux' named entity 'thrombus' named entity 'ticagrelor' named entity 'COVID-19' named entity 'venous thrombosis' named entity 'thrombosis' named entity 'atrial tachycardia' named entity 'balloon dilatation' named entity 'GP IIb/IIIa' named entity 'fibrinolytic therapy' named entity 'ECG' named entity 'intravenous infusion' named entity 'ITU' named entity 'STEMI' named entity 'coronary artery disease' named entity 'heparin' named entity 'COVID-19' named entity 'platelet' named entity 'ARDS' named entity 'platelet aggregation' named entity 'dual antiplatelet therapy' named entity 'mmol/L' named entity 'viral infection' named entity 'COVID-19' named entity 'prasugrel' named entity 'ECG' named entity 'chest pain' named entity 'C-reactive protein' named entity 'Intravenous' named entity 'STEMI' named entity 'eptifibatide' named entity 'COVID-19' named entity 'COVID-19' named entity 'intravenous fluids' named entity 'low blood pressure' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software